BAROLDI JOSEPH (Chief Business Officer) sold 54.7% of their position (5.63K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $451.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.87K
Price / share
$56.78
Trade value
$219.51K
% of position
Common Stock
Shares
+1.77K
Price / share
$32.60
Trade value
$57.67K
% of position
Common Stock
Shares
−5.63K
Price / share
$80.16
Trade value
$451.70K
% of position
Net shares
+0.00
Net value
-$174.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/26/2026 | M · Option Exercise | +3.87K | $56.78 | $219.51K | 82.8% | 4.67K | 8.54K |
| Common Stock Indirect | 6/26/2026 | M · Option Exercise | +1.77K | $32.60 | $57.67K | 20.7% | 8.54K | 10.30K |
| Common Stock Indirect | 6/26/2026 | S · Sale | −5.63K | $80.16 | $451.70K | 54.7% | 10.30K | 4.67K |
| Total | +0.00 | -$174.52K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
1.77K shares
Shares
−1.77K
Strike price
32.6
Held after
0.00
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
3.87K shares
Shares
−3.87K
Strike price
56.78
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Indirect | Common Stock1.77K shares | 6/26/2026 | M · Option Exercise | −1.77K | 32.6 | — | 0.00 |
| Non-Qualified Stock Option (right to buy) Indirect | Common Stock3.87K shares | 6/26/2026 | M · Option Exercise | −3.87K | 56.78 | — | 0.00 |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 48.52K | Direct |
| Total | 48.52K | 48.52K direct |